Serum adipocyte fatty acid‐binding protein (A‐FABP) is closely correlated to metabolic disorders such as obesity and insulin resistance (IR). Non‐alcoholic fatty liver disease (NAFLD) is a typical feature of IR… Click to show full abstract
Serum adipocyte fatty acid‐binding protein (A‐FABP) is closely correlated to metabolic disorders such as obesity and insulin resistance (IR). Non‐alcoholic fatty liver disease (NAFLD) is a typical feature of IR in the liver. The aim of this study was to explore the relationship between serum A‐FABP levels and NAFLD.
               
Click one of the above tabs to view related content.